PROMETRA PROGRAMMABLE PUMP SYSTEM
FDA premarket approval P080012/S031 · decided 2015-12-28
Approval details
- PMA number
- P080012
- Supplement
- S031
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol - OSB
- Trade name
- PROMETRA PROGRAMMABLE PUMP SYSTEM
- Generic name
- Pump, infusion, implanted, programmable
- Applicant
- Infusyn Therapeutics, LLC
- Date received
- 2015-10-20
- Decision date
- 2015-12-28
- Days to decision
- 69 days
- Decision code
- APPR
- Product code
- LKK
- Advisory committee
- General Hospital
- Expedited review
- No
- Location
- Hackettstown, NJ
- Statement
- APPROVAL OF THE FOLLOWING CHANGES TO THE POST-APPROVAL STUDY FOR THE DEVICE: A REVISION TO ALLOW FOR THE USE OF THE APPROVED PATIENT THERAPY CONTROLLER OR PTC IN THE POST-APPROVAL CLINICAL STUDY FOR THE PROMETRA IMPLANTABLE PROGRAMMABLE PUMP SYSTEM.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.